PATRICIA FINNEGAN: Open Payments
NPI 1821202334 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 8 payments from 6 companies in 2025. Trend: 2023 $99 · 2024 $51 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| GlaxoSmithKline, LLC. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Solventum Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $19 |
Products named: Lenvima, KEYTRUDA, JEMPERLI, LYNPARZA, ACTIV.A.C., ELAHERE.
Industry payments across NY — which companies pay providers there.
